celecoxib and ici d2138

celecoxib has been researched along with ici d2138 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Charlier, C; Durant, F; Goossens, JF; Goossens, L; Hénichart, JP; Houssin, R; Pommery, J; Pommery, N; Taverne, T; Telliez, A1
Aparoy, P; Chandramohan Reddy, T; Kalangi, SK; Kumar Reddy, K; Reddanna, P1
Bridoux, A; Henichart, JP; Millet, R; Pommery, J; Pommery, N1

Other Studies

3 other study(ies) available for celecoxib and ici d2138

ArticleYear
New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate cancer chemotherapy.
    Journal of medicinal chemistry, 2004, Dec-02, Volume: 47, Issue:25

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cyclooxygenase 2; Drug Screening Assays, Antitumor; Humans; Isoenzymes; Lipoxygenase Inhibitors; Male; Membrane Proteins; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Pyrazoles; Structure-Activity Relationship

2004
Pharmacophore modeling and virtual screening for designing potential 5-lipoxygenase inhibitors.
    Bioorganic & medicinal chemistry letters, 2010, Feb-01, Volume: 20, Issue:3

    Topics: Arachidonate 5-Lipoxygenase; Computer Simulation; Drug Design; Drug Evaluation, Preclinical; Lipoxygenase Inhibitors; Models, Chemical; Models, Molecular

2010
Synthesis and biological activity of N-aroyl-tetrahydro-gamma-carbolines.
    Bioorganic & medicinal chemistry, 2010, Jun-01, Volume: 18, Issue:11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Carbolines; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inhibitors; Humans; Indomethacin; Lipoxygenase Inhibitors; Male; Prostatic Neoplasms; Structure-Activity Relationship

2010